APA 6th Edition Bašić Kes, V., Zavoreo, I., Šerić, V., Vargek Solter, V., Cesarik, M., Hajnšek, S., ... Demarin, V. (2012). Recommendations for Diagnosis and Management of Multiple Sclerosis. Acta clinica Croatica, 51 (1), 117-135. Preuzeto s https://hrcak.srce.hr/85748
MLA 8th Edition Bašić Kes, Vanja, et al. "Recommendations for Diagnosis and Management of Multiple Sclerosis." Acta clinica Croatica, vol. 51, br. 1, 2012, str. 117-135. https://hrcak.srce.hr/85748. Citirano 21.08.2019.
Chicago 17th Edition Bašić Kes, Vanja, Iris Zavoreo, Vesna Šerić, Vesna Vargek Solter, Marijan Cesarik, Sanja Hajnšek, Marija Bošnjak Pašić, et al. "Recommendations for Diagnosis and Management of Multiple Sclerosis." Acta clinica Croatica 51, br. 1 (2012): 117-135. https://hrcak.srce.hr/85748
Harvard Bašić Kes, V., et al. (2012). 'Recommendations for Diagnosis and Management of Multiple Sclerosis', Acta clinica Croatica, 51(1), str. 117-135. Preuzeto s: https://hrcak.srce.hr/85748 (Datum pristupa: 21.08.2019.)
Vancouver Bašić Kes V, Zavoreo I, Šerić V, Vargek Solter V, Cesarik M, Hajnšek S i sur. Recommendations for Diagnosis and Management of Multiple Sclerosis. Acta clinica Croatica [Internet]. 2012 [pristupljeno 21.08.2019.];51(1):117-135. Dostupno na: https://hrcak.srce.hr/85748
IEEE V. Bašić Kes, et al., "Recommendations for Diagnosis and Management of Multiple Sclerosis", Acta clinica Croatica, vol.51, br. 1, str. 117-135, 2012. [Online]. Dostupno na: https://hrcak.srce.hr/85748. [Citirano: 21.08.2019.]
Sažetak Multiple sclerosis (MS) is a chronic demyelinating neurologic disorder that mainly affects young individuals (aged 20 to 50 years). Approximately 85% of patients experience an initial course with relapses and remissions (relapsing-remitting multiple sclerosis). Guidelines for the management of MS should be focused on three main areas: (a) the diagnosis of MS; (b) treatment of relapses; and (c) long-term preventive treatment including clinical follow up, dose adjustment, drug switch, control of therapeutic efficacy, and disease progression. Diagnosis should be established according to clinical and paraclinical criteria. Discussion on therapeutic recommendations is focused on the disease-modifying agents in acute phases and drugs for long-term treatment and symptomatic treatment. Differential diagnoses must be taken into account on making the diagnosis of MS. Therefore, diagnosis of MS should be established on clinical and radiological diagnostic criteria, cerebrospinal fluid analysis and evoked potentials.